Literature DB >> 4586374

Comparative study of alprenolol and methyldopa in previously untreated essential hypertension.

J A Vedin, C E Wilhelmsson, L Werkö.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4586374      PMCID: PMC458796          DOI: 10.1136/hrt.35.12.1285

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  23 in total

1.  Autoimmune haemolytic anaemia associated with alpha-methyldopa therapy.

Authors:  S M Worlledge; K C Carstairs; J V Dacie
Journal:  Lancet       Date:  1966-07-16       Impact factor: 79.321

2.  Incidence of a positive direct coombs test in patients on alpha-methyldopa.

Authors:  K C Carstairs; A Breckenridge; C T Dollery; S M Worlledge
Journal:  Lancet       Date:  1966-07-16       Impact factor: 79.321

3.  Effect of propranolol in mild hypertension.

Authors:  J W Paterson; C T Dollery
Journal:  Lancet       Date:  1966-11-26       Impact factor: 79.321

4.  Effect of methyldopa on plasma renin activity in man.

Authors:  S Mohammed; A F Fasola; P J Privitera; R J Lipicky; B L Martz; T E Gaffney
Journal:  Circ Res       Date:  1969-11       Impact factor: 17.367

5.  [Methyldopa in the therapy of hypertension].

Authors:  T Hilden; R Nilsson
Journal:  Tidsskr Nor Laegeforen       Date:  1968-07-15

6.  Some aspects of the long-term treatment of severe hypertension with methyldopa.

Authors:  M Hamilton
Journal:  Postgrad Med J       Date:  1968-01       Impact factor: 2.401

7.  Propranolol in hypertension.

Authors:  B N Prichard; P M Gillam
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

8.  Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist.

Authors:  B Ablad; M Brogård; L Ek
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1967

9.  Treatment of hypertension with propranolol.

Authors:  B N Prichard; P M Gillam
Journal:  Br Med J       Date:  1969-01-04

10.  Controlled trial of propranolol in hypertension.

Authors:  F J Zacharias; K J Cowen
Journal:  Br Med J       Date:  1970-02-21
View more
  5 in total

1.  Haemodynamic effects of beta-adrenorecptor blockers in hypertension.

Authors:  B Ablad; B Ljung; R Sannerstedt
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Double-blind comparison of metoprolol, alprenolol, and oxprenolol in hypertension.

Authors:  J Tuomilehto; A Nissinen
Journal:  Eur J Clin Pharmacol       Date:  1979       Impact factor: 2.953

3.  Controlled study of atenolol in treatment of hypertension.

Authors:  L Hansson; H Aberg; B E Karlberg; A Westerlund
Journal:  Br Med J       Date:  1975-05-17

4.  Dose-titrated, double-blind, cross-over comparison of a selective beta-blocker and methyldopa in the treatment of hypertension.

Authors:  P A Routledge; L V Zrinzo; J G Rao; R J Walden; D M Davies; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1977-03-11       Impact factor: 2.953

5.  Comparative study of metoprolol and alpha-methyldopa in untreated essential hypertension.

Authors:  R H Bergstrand; J A Vedin; C E Wilhelmsson; G Berglund
Journal:  Eur J Clin Pharmacol       Date:  1976       Impact factor: 2.953

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.